(Q46612312)

23 December 2017

title

De testimonio: on the evidence for decisions about the use of therapeutic interventions (English)

1 reference

23 December 2017

author name string

Michael Rawlins

series ordinal

1

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

23 December 2017

published in

The Lancet

1 reference

23 December 2017

volume

372

1 reference

23 December 2017

issue

9656

1 reference

23 December 2017

page(s)

2152-2161

1 reference

23 December 2017

A new system for grading recommendations in evidence based guidelines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

National Institute for Clinical Excellence and its value judgments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

No adjustments are needed for multiple comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Multiplicity in randomised trials II: subgroup and interim analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Randomized trials stopped early for benefit: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

When (not) to stop a clinical trial for benefit.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

More on subgroup analyses in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Statistics in medicine--reporting of subgroup analyses in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Bayesian statistics in medicine: a 25 year review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Domiciliary thrombolysis by general practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Bayesians and frequentists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

External validity of randomised controlled trials: "to whom do the results of this trial apply?".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

The causes and effects of socio-demographic exclusions from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Representation of the elderly, women, and minorities in heart failure clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Evidence from randomised trials on the long-term effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Clinical trials bureaucracy: unintended consequences of well-intentioned policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Sensible approaches for reducing clinical trial costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Reader's guide to critical appraisal of cohort studies: 1. Role and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Comparison of evidence of treatment effects in randomized and nonrandomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Randomised controlled trials and retrospective controls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

When are randomised trials unnecessary? Picking signal from noise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Design considerations for AIDS trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Hormone replacement therapy and heart disease: replacing dogma with data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Invited commentary: how far can epidemiologists get with statistical adjustment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Regular Aspirin Intake and Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Further experience of vitamin supplementation for prevention of neural tube defect recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Mendelian randomization: prospects, potentials, and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Bronchodilator treatment and deaths from asthma: case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Rauwolfia derivatives and breast cancer in hypertensive women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Reserpine use in relation to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Antihypertensive therapy and the risk of malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Reflections on controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Observational evidence for determining drug safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Teleoanalysis: combining data from different types of study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

Impact of participant and physician intervention preferences on randomized trials: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961930-3

7 January 2021

10.1016/S0140-6736(08)61930-3

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017